M

Mindbloom

Clinician-guided ketamine therapy for mental health

Overview

Mindbloom provides clinician-guided ketamine therapy for anxiety and depression, delivering customized treatment programs through partnerships with independently owned psychiatric medical practices. Treatments are prescribed and supervised by medically licensed clinicians and can be delivered in-person or via telehealth. The therapy works by administering ketamine under clinician oversight as part of a personalized program designed to address each patient’s mental health needs, with safety protocols and ongoing symptom monitoring. What sets Mindbloom apart from competitors is its model of working with established psychiatric practices to ensure medical supervision, its large clinical footprint of over 300,000 completed sessions, and its emphasis on safety and efficacy while tailoring plans to individual challenges. The company’s goal is to increase access to science-backed mental health treatments and transform lives through practical, clinician-guided care.

Work here?Claim your company

About Mindbloom

Simplify's Rating
Why Mindbloom is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Company Size

1-10

Company Stage

Seed

Total Funding

$3.2M

Headquarters

Seattle, WA

Founded

2008

Get referred to Mindbloom

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • June 14, 2024 study of 11,441 clients showed 62% symptom improvement and 28% remission.
  • June 18, 2024 PTSD program and November 15, 2024 mindfulness partnership broaden use cases.
  • October 5, 2026 update says Mindbloom has nearly 600,000 sessions, validating demand and scale.

What critics are saying

  • November 3, 2026 Vermont filing exposed Mindbloom health records, triggering class-action scrutiny.
  • Ketamine remains off-label for depression and anxiety, inviting FDA and state telehealth pressure.
  • A serious breach undermines trust in mental-health data, threatening patient acquisition and retention.

What makes Mindbloom unique

  • Mindbloom runs at-home ketamine therapy across 38 states, cutting IV clinic friction.
  • Its September 2025 injectable protocol adds dosing precision and patient preference advantages.
  • Mindbloom pairs medication with coaching, content, and community, not drug delivery alone.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$3.2M

Meets

Industry Average

Funded Over

2 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$1.8M
$2M
$2.3M
$3M

Benefits

  • Remote Work Options
  • Flexible Work Hours
  • Health Insurance

Company News

Ahdout Wolfson
Nov 6th, 2026
Mindbloom Provider Group, PA data breach.

Mindbloom Provider Group, PA data breach. Ahdoot & Wolfson is investigating a possible class action lawsuit involving Mindbloom Provider Group, PA, following a reported data breach involving health records. According to a filing with the Vermont Attorney General dated November 3, 2026, Mindbloom reported a data breach involving this category of information. The dates of the breach and its discovery have not been publicly disclosed. If you received a data breach notification from Mindbloom, or are a current or former Mindbloom patient, you may contact Ahdoot & Wolfson to learn more about the investigation. * Compromised Data Volume: The total number of individuals potentially affected has not been publicly disclosed. The Vermont Attorney General's listing identifies one Vermont resident, but this does not establish the total number of people affected nationwide. * Information: The information category listed in the Vermont Attorney General's filing is health records. The specific information potentially involved has not been publicly disclosed. * Account Records: The number of potentially affected accounts or records has not been publicly disclosed. * Operational Documents: No specific operational documents or additional categories of information have been identified in the available filing. * Potential Risks: If health records were exposed, affected individuals may face privacy concerns and potential misuse of their personal information. The specific information involved and any resulting risks have not been established. If you received a data breach notification from Mindbloom, or are a current or former Mindbloom patient, complete the form below to learn more about the investigation. Attorney Advertising.

Spirit Tech
Aug 16th, 2026
Weekly digest - aug 16, 2026.

Weekly digest - aug 16, 2026. One email a week - the signal SPIRIT is sensing in the field. Unsubscribe anytime. The 2 big things in Spirit Tech this week: Two peer-reviewed papers, days apart, reached the same two-sided verdict on EEG meditation and neurofeedback technology. A Frontiers in Artificial Intelligence study showed that machine learning classifiers can distinguish Shamatha, Vipassana, and Metta meditation from mind-wandering with high accuracy when trained on a single meditator's EEG data. Across different meditators, accuracy dropped sharply. The same week, a Frontiers in Neuroscience systematic review took stock of the wider field: 25 studies since 2021 of closed-loop EEG neurofeedback, applied to ADHD, PTSD, chronic pain, and anxiety. Its verdict was two-sided. The systems technically work, decoding the target brain rhythms and delivering live feedback, and small trials reported real symptom drops, pain relief in most patients in one study and reductions in PTSD and ADHD scores in others. But almost every study was a pilot of ten to thirty people, few used sham controls, and only two followed patients past twelve weeks, so durable clinical benefit is unproven. The frontier for consumer neurofeedback is clear: it works and the early therapeutic signals are encouraging, but the technology cannot yet generalize across users or show its effects last. Fireside's Lucy AI, a simulator that lets clinicians rehearse psychedelic therapy on an AI patient, drew a major endorsement from one of the field's most authoritative researchers. The endorsement came from Dr. Rachel Yehuda, who directs Mount Sinai's Parsons Research Center for Psychedelic Healing, ran the first MDMA-assisted therapy trial inside the VA system and trained its therapists by hand, on top of thirty years establishing that trauma leaves biological marks that pass to the next generation. She is as authoritative as the field gets. Her group is now working with Fireside on Lucy, an AI that plays a patient taking MDMA or psilocybin so trainees can rehearse the hardest moments and be scored, against scales like the Therapist Empathy Scale, before they ever sit with a real person. It learns from Fireside Project's 7,000-plus real conversations with people in the middle of psychedelic experiences, which is why her one caveat is about the data: "what Lucy gets fed determines how well Lucy is going to perform." The bottleneck in psychedelic therapy is no longer the drugs, it is the people, and therapists are still trained the slow way, cohort by cohort, by the few qualified to teach it. That makes the training layer a clear opening in psychedelic therapy for Spirit Tech, with a catch Dr. Yehuda names herself: the tools are arriving before the field has agreed what good practice is, and "we're not even sure what we want to scale yet." Top jobs. * Founding PMHNP @ Mindbloom: Set the clinical protocols for a new Austin clinic at the largest US provider of at-home ketamine therapy, which has delivered 800,000+ sessions across 38 states. Austin, TX (hybrid). * Senior/Principal Graphics Engineer @ Thatgamecompany: Build the C++ rendering systems for the proprietary engine behind Sky and Journey, games built around wonder and connection. Remote (US/Canada) · $150k-$220k. * Director of Visual Content @ YouVersion: Lead visual storytelling across video, photography, and motion for the worldwide Bible app. Edmond, OK. Browse the Spirit Tech jobs board for more roles, or to post one at your organization.

PR Newswire
Nov 15th, 2024
Mindbloom And Happier Break New Ground With The Ultimate Fusion Of Ketamine Therapy And Mindfulness

AUSTIN, Texas, Nov. 15, 2024 /PRNewswire/ -- Today, Mindbloom, the largest provider of psychedelic therapy, and Happier, the leading meditation and habit-building app, announce Continuous Transformation – a partnership to enable people to deepen their mindfulness practices and unlock emotional healing

Crain Communications
Jun 19th, 2024
Mindbloom publishes the results of largest ketamine study to date

In addition to the positive study results, Mindbloom also announced the launch of a ketamine therapy program designed for people recovering from PTSD.

PR Newswire
Jun 18th, 2024
Mindbloom Launches Expert-Led Psychedelic Therapy For Ptsd

The program combines Mindbloom's ketamine therapy protocol with preparation, integration, and in-session content from Shari Botwin , a leading trauma therapist, author, and survivor of PTSDAUSTIN, Texas, June 18, 2024 /PRNewswire/ -- Mindbloom , the largest provider of psychedelic medicine, today announced the launch of a first-of-its-kind ketamine therapy program designed for people recovering from PTSD.PTSD is a leading cause of disability in the United States, affecting 13 million people every year – but FDA has not approved any new PTSD treatments in 25 years.Mindbloom"Seventeen veterans die from suicide every day because last-generation treatments like antidepressants and psychotherapy aren't working" said Mindbloom CEO and Founder Dylan Beynon. "Congress and the VA are taking steps to support psychedelic medicine, but with FDA approval of MDMA therapy in question, Mindbloom is ensuring that trauma survivors don't have to wait for treatment that could save their lives."Mindbloom's new program includes ketamine therapy protocols that have shown incredible effectiveness for depression and anxiety , and combines them with content from trauma expert Shari Botwin:Six ketamine therapy sessions focusing on unique issues, including Conquering Guilt, Rising Above Shame, Learning to Trust Yourself, Learning to Trust Others, Healing Through Grieving, and Reclaiming What Was Lostfocusing on unique issues, including Conquering Guilt, Rising Above Shame, Learning to Trust Yourself, Learning to Trust Others, Healing Through Grieving, and Reclaiming What Was Lost Audio, video, and written content by Shari Botwin for preparation, treatment, and integrationfor preparation, treatment, and integration One-on-one coaching from Mindbloom guides, and access to group integration circles"This program is designed for people who have experienced traumatic events of various kinds and, just like me, are hoping to live full, safe and happy lives, Botwin says. "While no one walks away from trauma feeling the exact same thing, my hope is to share insights, tools, and practices that cover the broad spectrum of unmanageable and horrific life experiences to help survivors heal."Mindbloom's new program adds to a library of expert-led programs for unique mental health challenges:About Mindbloom:Mindbloom is the largest provider of psychedelic medicine, offering ketamine therapy programs that combine evidence-based medicine with coaching, content, and community. Mindbloom's psychiatric clinicians facilitate over 275,000 at-home ketamine therapy sessions each year in 36 states, and Mindbloom's remarkable treatment outcomes were published in the largest peer-reviewed study of ketamine therapy. For more information, visit www.mindbloom.com .About Shari Botwin:Shari Botwin, LCSW, has counseled survivors in recovery from all types of traumas in her Cherry Hill, New Jersey private practice for over twenty-eight years. She has written three books, and her latest – Stolen Childhoods: Thriving After Abuse – focuses on reclaiming life in adulthood for survivors of childhood abuse

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Mindbloom right now.

Find jobs on Simplify and start your career today

We update Mindbloom's jobs every few hours, so check again soon!Browse all jobs